Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia [PDF]
Elizabeth Slaney +5 more
openalex +1 more source
P01-031 – Anakinra for colchicine resistant FMF [PDF]
Ilan Ben‐Zvi +8 more
openalex +1 more source
Differential response to anakinra and adalimumab in a patient with DADA2 syndrome [PDF]
Bahtiyar Toz +4 more
openalex +1 more source
Perspective on Corticosteroid Use and Interleukin-1 Inhibition With Anakinra in Pericarditis During Pregnancy. [PDF]
Trotta L +3 more
europepmc +1 more source
Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra [PDF]
A.L. Manson +12 more
core +1 more source
Acute interleukin-1β antagonism decreases systemic inflammation, increases GLP-1 release, and modulates insulin secretion in individuals with prediabetes. [PDF]
Fischer JS +5 more
europepmc +1 more source
Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial. [PDF]
Ambite I +6 more
europepmc +1 more source
Reply: Perspective on Corticosteroid Use and Interleukin-1 Inhibition With Anakinra in Pericarditis During Pregnancy. [PDF]
Schmitz KT +4 more
europepmc +1 more source
Severe Cytokine Release Syndrome After CAR T Cell Therapy in a Pediatric Patient With Relapsed ALL. [PDF]
Alotaibi A, Alajmi N, Alnuhait M.
europepmc +1 more source

